209 related articles for article (PubMed ID: 28423318)
1. Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.
López-Juárez A; Titus HE; Silbak SH; Pressler JW; Rizvi TA; Bogard M; Bennett MR; Ciraolo G; Williams MT; Vorhees CV; Ratner N
Cell Rep; 2017 Apr; 19(3):545-557. PubMed ID: 28423318
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte RasG12V expressed in its endogenous locus disrupts myelin structure through increased MAPK, nitric oxide, and notch signaling.
Titus HE; López-Juárez A; Silbak SH; Rizvi TA; Bogard M; Ratner N
Glia; 2017 Dec; 65(12):1990-2002. PubMed ID: 28856719
[TBL] [Abstract][Full Text] [Related]
3. Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.
Mayes DA; Rizvi TA; Titus-Mitchell H; Oberst R; Ciraolo GM; Vorhees CV; Robinson AP; Miller SD; Cancelas JA; Stemmer-Rachamimov AO; Ratner N
Cell Rep; 2013 Sep; 4(6):1197-212. PubMed ID: 24035394
[TBL] [Abstract][Full Text] [Related]
4. Brain-wide structural and functional disruption in mice with oligodendrocyte-specific
Asleh J; Shofty B; Cohen N; Kavushansky A; López-Juárez A; Constantini S; Ratner N; Kahn I
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22506-22513. PubMed ID: 32839340
[TBL] [Abstract][Full Text] [Related]
5. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
6. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis.
Jurynczyk M; Jurewicz A; Bielecki B; Raine CS; Selmaj K
J Neuroimmunol; 2005 Dec; 170(1-2):3-10. PubMed ID: 16290267
[TBL] [Abstract][Full Text] [Related]
8. Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants.
Bennett MR; Rizvi TA; Karyala S; McKinnon RD; Ratner N
J Neurosci; 2003 Aug; 23(18):7207-17. PubMed ID: 12904481
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between F3/contactin and Notch at axoglial interface: a role in oligodendrocyte development.
Hu QD; Ma QH; Gennarini G; Xiao ZC
Dev Neurosci; 2006; 28(1-2):25-33. PubMed ID: 16508301
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
[TBL] [Abstract][Full Text] [Related]
12. JNK inhibitors increase osteogenesis in Nf1-deficient cells.
Sullivan K; El-Hoss J; Little DG; Schindeler A
Bone; 2011 Dec; 49(6):1311-6. PubMed ID: 21964323
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
14. The NF1 tumor suppressor critically regulates TSC2 and mTOR.
Johannessen CM; Reczek EE; James MF; Brems H; Legius E; Cichowski K
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8573-8. PubMed ID: 15937108
[TBL] [Abstract][Full Text] [Related]
15. Overcoming failure to repair demyelination in EAE: gamma-secretase inhibition of Notch signaling.
Jurynczyk M; Jurewicz A; Bielecki B; Raine CS; Selmaj K
J Neurol Sci; 2008 Feb; 265(1-2):5-11. PubMed ID: 17949754
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells.
Li F; Munchhof AM; White HA; Mead LE; Krier TR; Fenoglio A; Chen S; Wu X; Cai S; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1921-30. PubMed ID: 16644864
[TBL] [Abstract][Full Text] [Related]
17. Morphological and functional characterization of predifferentiation of myelinating glia-like cells from human bone marrow stromal cells through activation of F3/Notch signaling in mouse retina.
Lu L; Chen X; Zhang CW; Yang WL; Wu YJ; Sun L; Bai LM; Gu XS; Ahmed S; Dawe GS; Xiao ZC
Stem Cells; 2008 Feb; 26(2):580-90. PubMed ID: 17975227
[TBL] [Abstract][Full Text] [Related]
18. Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.
Hannan F; Ho I; Tong JJ; Zhu Y; Nurnberg P; Zhong Y
Hum Mol Genet; 2006 Apr; 15(7):1087-98. PubMed ID: 16513807
[TBL] [Abstract][Full Text] [Related]
19. NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development.
Sanchez-Ortiz E; Cho W; Nazarenko I; Mo W; Chen J; Parada LF
Genes Dev; 2014 Nov; 28(21):2407-20. PubMed ID: 25367036
[TBL] [Abstract][Full Text] [Related]
20. CNS myelinogenesis in vitro: myelin basic protein deficient shiverer oligodendrocytes.
Seiwa C; Kojima-Aikawa K; Matsumoto I; Asou H
J Neurosci Res; 2002 Aug; 69(3):305-17. PubMed ID: 12125072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
